MedTrace Logo

Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography

NCT00950079 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 368

Last updated 2009-07-31

No results posted yet for this study

Summary

The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing coronary angiography or intervention.

Conditions

  • Contrast Induced Nephropathy

Interventions

DRUG

Sodium bicarbonate

3 mL/kg for 1 hour immediately before contrast injection , 1mg/kg/hr during procedure and 6 hours after procedure

DRUG

saline

0.9% normal saline with 1 mL/kg/hr infusion 12 hours before procedure and 12 hours after procedure

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    lead OTHER

Principal Investigators

  • Seong-Wook Park, MD, PhD · Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-08-31
Completion
2010-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00950079 on ClinicalTrials.gov